TLDR
- P&G reported Q3 fiscal 2026 EPS of $1.59 adjusted, beating the $1.56 estimate
- Revenue came in at $21.24 billion, topping Wall Street’s $20.5 billion forecast
- Volume grew 2% year-on-year — the first positive volume reading in a year
- Beauty division led the way with 5% volume growth; grooming and health care lagged
- Full-year guidance was reiterated, with EPS growth projected at 1%–6%
Procter & Gamble posted a solid fiscal third quarter on Friday, beating both earnings and revenue estimates. The stock rose around 4% in premarket trading following the results.
The Procter & Gamble Company, PG
The company reported adjusted EPS of $1.59, ahead of the $1.56 analysts expected. Revenue came in at $21.24 billion, up 7% year-on-year and well above the $20.5 billion consensus estimate.
Organic sales, which strip out currency moves, acquisitions and divestitures, rose 3%.
Procter & Gamble $PG +3.1% before the bell, after the products manufacturer posted a top-line beat for the first quarter reiterated its full-year outlook. PG will be looking to add more distance between its year-to-date breakeven level. https://t.co/9wdjpUXjHM
— Schaeffer's Investment Research (@schaeffers) April 24, 2026
One of the cleaner wins in the report was volume. P&G posted 2% volume growth for the quarter — the first time in a year the company has grown volume across the whole business.
Volume matters more than headline sales for a company like P&G. It strips out pricing effects and gives a cleaner read on actual demand.
CFO Andre Schulten described the U.S. consumer as “stable,” while noting that bifurcation between consumer segments is continuing. That’s a polite way of saying lower-income shoppers are still under pressure.
The beauty segment — home to Olay, Head & Shoulders and Pantene — was the standout. It posted 5% volume growth, with gains across personal care, skin care and hair care.
Baby, feminine and family care followed with 3% volume growth, driven by stronger demand for diapers and family care products including Bounty and Charmin.
Fabric and home care, which includes Tide, grew volume 2%, helped by North American demand.
Where It Struggled
Not every segment kept pace. Grooming — which includes Gillette and Venus — saw volume fall 2%. Health care, covering Oral-B and Vicks, also dropped 2%.
Operating margin came in at 21.5%, down from 23.3% in the same period last year. Gross margin also missed analyst expectations, a point worth watching.
What’s Ahead
P&G reiterated its full-year outlook. The company is guiding for sales growth of 1%–5% and net EPS growth of 1%–6%, with full-year adjusted EPS guidance at $6.96 at the midpoint.
CEO Shailesh Jejurikar said the company is increasing investment to build consumer momentum despite a challenging economic backdrop.
One headwind flagged for Q4: a projected $150 million cost increase, driven largely by higher transportation costs tied to rising fuel prices.
Free cash flow margin held steady at 14.3%, roughly in line with the same period last year.
The stock was trading up approximately 2.6% to $149.47 shortly after the report, before extending gains to around 4% in premarket.
🚨 Our April Stock Picks Are Live!
A new month means new opportunities. Our analysts have just released their top stock picks for April, highlighting companies with strong momentum that rank highly on our KO Score algorithm. We’re also now sharing trade ideas for both long-term and short-term investors, giving you more ways to spot potential opportunities in the market.
Sign up to Knockout Stocks today and get 50% off to unlock the full list and see which stocks made the cut.
Use coupon code Special50 for your exclusive discount!
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
